PharmAust Management

Management criteria checks 1/4

PharmAust's CEO is Michael Thurn, appointed in May 2024, has a tenure of less than a year. total yearly compensation is A$415.11K, comprised of 69.4% salary and 30.6% bonuses, including company stock and options. directly owns 0.53% of the company’s shares, worth €301.70K. The average tenure of the management team and the board of directors is 0.4 years and 0.4 years respectively.

Key information

Michael Thurn

Chief executive officer

AU$415.1k

Total compensation

CEO salary percentage69.4%
CEO tenureless than a year
CEO ownership0.5%
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Michael Thurn's remuneration changed compared to PharmAust's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$415kAU$288k

-AU$9m

Compensation vs Market: Michael's total compensation ($USD284.09K) is below average for companies of similar size in the German market ($USD503.65K).

Compensation vs Earnings: Insufficient data to compare Michael's compensation with company performance.


CEO

Michael Thurn

less than a year

Tenure

AU$415,107

Compensation

Dr. Michael Thurn, Ph D., serves as Managing Director, CEO and Director of PharmAust Limit since May 31, 2024. He was Chief Executive Officer of PharmAust Limited from September 1, 2023 and was its Directo...


Leadership Team

NamePositionTenureCompensationOwnership
Michael Thurn
MD, CEO & Directorless than a yearAU$415.11k0.53%
A$ 301.7k
John Clark
Chief Operating Officerless than a yearAU$153.58k0.13%
A$ 73.7k
Nicky Wallis
Chief Scientific Officerless than a yearAU$26.16kno data
Fiona Milner
General Manager of Epichem Pty Ltd2.3yrsAU$26.69kno data
Gary Pitt
Head of Chemistryno datano datano data
James Rixson
Head of Productionno datano datano data
Herbert Brinkman
Head of Manufacturingless than a yearno datano data
Stefan Ross
Company Secretaryless than a yearno datano data

0.4yrs

Average Tenure

Experienced Management: ECQ's management team is not considered experienced ( 0.4 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Michael Thurn
MD, CEO & Directorless than a yearAU$415.11k0.53%
A$ 301.7k
Kathryn MacFarlane
Directorless than a yearAU$3.13kno data
Christian Schirvel
Veterinary Clinical Advisory Board Member7yrsno datano data
Angela Frimberger
Veterinary Clinical Advisory Board Chair7yrsno datano data
Barbara Kitchell
Veterinary Advisory Board Member6.8yrsno datano data
Marcus Hughes
Directorless than a yearAU$10.80k2.43%
A$ 1.4m
Sergio Duchini
Non-Executive Chairmanless than a yearAU$9.38kno data

0.4yrs

Average Tenure

Experienced Board: ECQ's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.